Mikai Introduces New Minimally Invasive Falena Interspinous Device to Treat Common Degenerative Spinal Disorders

Share this story with your network

GENOVA, Italy–(BUSINESS WIRE)–Mikai, S.p.A. ®, a privately held medical device company, announced the market launch of its patented Falena® Interspinous Decompression Device. Falena®, a small titanium and PEEK implant inserted during minimally invasive back surgery, treats lumbar spinal stenosis (LSS) providing patient pain relief.

LSS is a narrowing of the spinal canal in the lower back that can irritate the nerves that branch from the spinal cord and is most often a result of aging and everyday wear on the spine commonly occurring in people over age 50. LSS may cause progressive low back pain with or without radiation, numbness or weakness in the buttocks and legs and symptoms that improve with resting, lying down or bending forward.

“Using local anesthesia, we found the Falena® procedure simple and straightforward. The initial post-surgery results are excellent with spinal decompression and flexion preservation achieved and almost immediate patient pain relief,” according to Prof. Giovanni Simonetti and Prof. Salvatore Masala of University Hospital Tor Vergata in Rome, Italy.

Leave a Comment

Your email address will not be published. Required fields are marked *

*